Glycopyrrolate Injection USP 0.4 mg (Glycopyrrolate SOLUTION) 0.4 MG

Glycopyrrolate Injection USP 0.4 mg is a medication used to reduce secretions and manage certain conditions. This intramuscular solution is manufactured by Sterimax Inc. in Canada.

Strength

0.4 MG

Pack Size

10X2ML

Manufacturer / TM Owner

STERIMAX INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Glycopyrrolate Injection USP 0.4 mg is commonly used to reduce excessive secretions in the respiratory tract. It may also be used to manage conditions that require the reduction of stomach acid or to control certain types of muscle spasms. This medication is often administered intramuscularly to achieve the desired effects.

Side Effects

Glycopyrrolate Injection USP 0.4 mg may cause dry mouth, blurred vision, or constipation. Some individuals might experience dizziness or drowsiness. These effects can vary depending on the individual and the specific condition being treated.

Precautions & Warnings

Glycopyrrolate Injection USP 0.4 mg should be handled with care. It is important to follow the instructions provided by a healthcare professional. This medication should be stored properly to maintain its effectiveness and safety.

Avoid Interactions

Glycopyrrolate Injection USP 0.4 mg may interact with other medications, including those that affect the central nervous system or other anticholinergic drugs. It is important to inform a healthcare professional about all medications being taken to avoid potential interactions.

Frequently Asked Questions

Glycopyrrolate Injection USP 0.4 mg is used to reduce secretions and manage conditions that require the reduction of stomach acid or control of muscle spasms.

Glycopyrrolate Injection USP 0.4 mg is typically administered intramuscularly.

Common effects may include dry mouth, blurred vision, constipation, dizziness, or drowsiness.

Glycopyrrolate Injection USP 0.4 mg is manufactured by Sterimax Inc. in Canada.

It is important to follow the instructions provided by a healthcare professional and store the medication properly.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.